[BHVN] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[BHVN] Biohaven Pharmaceutical Holding Company Ltd.
Announcement Date
10-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -87.01%
YoY- 63.38%
Quarter Report
BHVN's Result
BHVN's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue -215,079 0 215,079 318,852 190,013 135,740 92,933 -
PBT -215,250 -67,637 -197,177 -89,777 -49,429 -55,497 -206,809 2.69%
Tax -14,143 1,216 6,110 7,255 2,457 -1,132 4,350 -
NP -201,107 -68,853 -203,287 -97,032 -51,886 -54,365 -210,619 -3.02%
Tax Rate - - - - - - - -
Total Cost -13,972 68,853 418,366 415,884 241,899 190,105 303,552 -
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 93.50 0.00 -94.52 -30.43 -27.31 -40.05 -226.64 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -3.30 -1.75 -5.67 -2.71 -1.45 -1.52 -3.23 1.43%
EPS Diluted -3.30 -1.75 -5.67 -2.71 -1.45 -1.52 -3.23 1.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.